Guidewire Software Inc. Common Stock vs NeoGenomics Inc. Common Stock — how do they compare? Guidewire Software Inc. Common Stock trades at $163.81 (market cap $13.52B), while NeoGenomics Inc. Common Stock trades at $17.17 (market cap $2.17B). The key difference: Guidewire Software Inc. Common Stock is far larger — about 6.2× NeoGenomics Inc. Common Stock's market cap, and NeoGenomics Inc. Common Stock is trading nearer its 52-week high, Guidewire Software Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Guidewire Software Inc. Common Stock for 0 Days and NeoGenomics Inc. Common Stock for 0 Days on average.
| GWRE | NEO | |
|---|---|---|
Market Cap | $13.52B | $2.17B |
Volume | 897,708 | 1,615,943 |
Sector | Technology | Health |
52-Week High | $254.23 | $19.91 |
52-Week Low | $102.69 | $7.19 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $13.48B | $2.47B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Guidewire Software Inc. develops InsuranceSuite Cloud, a software platform used by property and casualty insurers for policy administration, billing, and claims processing.
Read more on GWRE →NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →